Pulmonary Medicine

Lisa R. Young, MD

Title

Director, Pediatric Rare Lung Diseases Program, Division of Pulmonary Medicine

Appointment

Assistant Professor of Pediatrics and Medicine, Division of Pulmonary Medicine

Email

lisa.young@cchmc.org

Phone

513-636-6771

Fax

513-636-4615

Credentials

BA: University of Virginia, Charlottesville, VA 1993.
MD: Duke Univeristy School of Medicine, Durham, NC 1997.
Residency: Internal Medicine and Pediatrics, Duke University Medical Center, Durham, NC 2001.
Fellowship: Pediatric Pulmonology and Pulmonary and Critical Care Medicine Cincinnati Children's Hospital Medical Center and the University of Cincinnati 2005.
Certifications: Internal Medicine, 2001; Pediatrics, 2001; Pediatric Pulmonology, 2006; Adult Pulmonary Medicine (ABIM), 2006.

Awards and Honors

Best Doctors in America, 2008
Central Society for Clinical Research, Early Career Development Award, 2008
American Thoracic Society Carl Booberg Research Award, 2007
Procter Research Scholar, Cincinnati Children's Hospital Medical Center, 2005-2007
Member, Writing Group, American Thoracic Society Consensus Statement on the Approach to the Young Child with Interstitial Lung Disease, 2005-present
First place, Basic Science, University of Cincinnati, Department of Medicine, "Trainee Research Grand Rounds", 2005

Research Grants and Contracts

Lymphangioleiomyomatosis (LAM) Foundation Pilot Project Grant: 1/1/08 – 12/31/08; Utility of VEGF-D as a Biomarker in Lymphangioleiomyomatosis; Principal Investigator
.

American Thoracic Society Research Grant: 1/1/07-12/30/08; Alveolar Cell Dysfunction in Pulmonary Fibrosis; Principal Investigator
.

Parker B. Francis Foundation: 7/1/07-6/30/10;
Parker B. Francis Fellowship; Principal Investigator

NHLBI 1 K08 HL082757-01: 9/1/07 to 8/31/12; Alveolar Cell Dysfunction and Pulmonary Fibrosis; Principal Investigator

Publications, Most Recent

LR Young, Y Inoue, FX McCormack. Diagnostic Potential of Serum VEGF-D for Lymphangioleiomyomatosis.New England Journal of Medicine 2008;358:199-200.

JJ Bissler, FX McCormack, LR Young, JM Elwing, G Chuck, JM Leonard, VJ Schmithorst, T Laor, AS Brody, JA Bean, S Salisbury, DN Franz. Efficacy and Safety of Sirolimus for Angiomyolipomata in Patients with Tuberous Sclerosis Complex and Lymphangioleiomyomatosis. New England Journal of Medicine 2008;358:140-51.

LR Young, LM Nogee, B Barnett, RJ Panos, TV Colby, GH Deutsch. Usual Interstitial Pneumonia (UIP) in an Adolescent with ABCA3 Mutations.Chest 2007;November:[accepted for publication].

GH Deutsch, LR Young*, RR Deterding, LL Fan, SD Dell, JA Bean, AS Brody, LM Nogee, BC Trapnell, C Langston and the Pathology Cooperative Group. Cross-sectional Evaluation of Diffuse Lung Disease in Young Children: Application of a Novel Clinical-Pathologic Classification Scheme.AJRCCM, published ahead of print on September 20, 2007 as doi:10.1164/rccm.200703-393OC.

HD Thomas, K Risma, TB Graham, AS Brody, LR Young, PM Joseph. A Kindred of Children with Interstitial Lung Disease.Chest 2007;132:221-30.

LR Young, R Pasula, PM Gulleman, GH Deutsch, FX McCormack. Susceptibility of Hermansky-Pudlak Mice to Bleomycin-Induced Type II Cell Apoptosis and Fibrosis.AJRCMB 2007;37:67-74.

AL Prestridge, JL Wooldridge, GH Deutsch, LR Young, SE Wert, JA Whitsett, L Nogee. Persistent Tachypnea and Hypoxia in a 3-month-old Term Infant (ABCA3).J Pediatr 2006;149:702-6.

K Almoosa, J Mendez, J Huggins, LR Young, M Coutinho, S Byrnes, E Sullivan, J Ryu, SP Bar-Ziv, J Maurer, FX McCormack, S Sahn. Pneumothorax in Lymphangioleiomyomatosis.Chest 2006;129:1274-81.

LR Young, K Almoosa, SP BarZiv, M Coutinho, FX McCormack, and S Sahn. Patient Perspectives on Pneumothorax and Management in Lymphangioleiomyomatosis.Chest 2006;129:1267-73.

LR Young, MT Borchers, R Gibbons, H Allen, FX McCormack. Lung Restricted Macrophage Activation in the Pearl Mouse Model of Hermansky Pudlak Syndrome.J Immunology 2006;176(7):4361-8.

MT Borchers, NL Harris, SC Wesselkamper, S Zhang, Y Chen, LR Young, GW Lau. The NKG2D Activating Receptor Mediates Pulmonary Clearance of Pseudomonas aeruginosa.Infection and Immunity 2006;74(5):2578-86.

F Kong, LR Young, H Ran, M Meyers, Y Chen, P Joseph, DJ Hassett, GW Lau. Pseudomonas Aeruginosa Pyocyanin Inactivates Lung Epithelial V-ATPase Activity, Thereby Inhibiting Expression and Trafficking of the Cystic Fibrosis Transmembrane Regulator.Cell Microbiology 2006;8(7):1121-33.